GlassScriptPrepare for your visit
Syed Hasan
Dayton, OH · NPI 1003835505
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,091.10
in general payments reported to CMS, 2019-2025 · $441 in 2025
The $441 reported for 2025 was more than what 76% of providers received nationally.
Who reported paying
General payments only, top 6 by amount.
- Alcon Vision LLC $619.11
- Abbvie INC. $244.47
- Bausch & Lomb, A Division of Bausch Health US, LLC $170.45
- Ivantis, INC $150.00
- Aerie Pharmaceuticals, INC. $139.27
- Johnson & Johnson Surgical Vision, INC. $128.30
Drugs and devices associated with these payments
Lumigan Tecnis Iol Hydrus Microstent Rocklatan Simbrinza Vyzulta Miebo Gattex Clareon Ozurdex Iyuzeh Alphagan P
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Syed Hasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/181709/syed-hasan